Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment

Journal of Affective Disorders

Volumn 146, Issue 2, 2013, Pages 262-265

  Garakani, Amir ^a,e   Martinez, Jose M ^b   Yehuda, Rachel ^a,c   Gorman, Jack M ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c James J Peters Veterans Affairs Hospitals Medical Center   (United States)

^d Franklin Behavioral Health Consultants   (United States)

^e SILVER HILL HOSPITAL   (United States)

Author keywords

Antidepressant; Corticotropin releasing factor (CRF); Glutamine; Major depressive disorder (MDD); Stress; Venlafaxine

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; GLUTAMIC ACID; GLUTAMINE; VENLAFAXINE;

ADULT; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE ESCALATION; FEMALE; HUMAN; LUMBAR PUNCTURE; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SUICIDAL IDEATION;

ADULT; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; CORTICOTROPIN-RELEASING HORMONE; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; FEMALE; GLUTAMIC ACID; GLUTAMINE; HUMANS; MALE; MIDDLE AGED; SUICIDAL IDEATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875221693     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.06.037     Document Type: Article

References (24)

1. C.M. Banki, L. Karmacsi, G. Bissette, and C.B. Nemeroff CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse European Neuropsychopharmacology 2 1992 107 113
2. A.J. Bechtholt-Gompf, H.V. Walther, M.A. Adams, W.A. Carlezon, D. Ongur, and B.M. Cohen Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory Neuropsychopharmacology 35 2010 2049 2059
3. A.T. Beck, M. Kovacs, and A. Weissman Assessment of suicidal intention: the scale for suicide ideation Journal of Consulting and Clinical Psychology 47 1979 343 352
4. L.L. Carpenter, A.R. Tyrka, C.J. McDougle, R.T. Malison, M.J. Owens, C.B. Nemeroff, and L.H. Price Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects Neuropsychopharmacology 29 2004 777 784
5. M.D. De Bellis, P.W. Gold, T.D. Geracioti Jr., S.J. Listwak, and M.A. Kling Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression American Journal of Psychiatry 150 1993 656 657
6. M.A. Frye, G.E. Tsai, T. Huggins, J.T. Coyle, and R.M. Post Low cerebrospinal fluid glutamate and glycine in refractory affective disorder Biological Psychiatry 61 2007 162 166
7. S.F. Gao, and A.M. Bao Corticotropin-releasing hormone, glutamate, and γ-aminobutyric acid in depression Neuroscientist 17 2011 124 144
8. J.M. Gorman, and J.P. Docherty A hypothesized role for dendritic remodeling in the etiology of mood and anxiety disorders Journal of Neuropsychiatry and Clinical Neurosciences 22 2010 256 264
9. I. Heuser, G. Bissette, M. Dettling, U. Schweiger, U. Gotthardt, J. Schmider, C.H. Lammers, C.B. Nemeroff, and F. Holsboer Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment Depression and Anxiety 8 1998 71 79
10. M.A. Kling, A. Roy, A.R. Doran, J.R. Calabrese, D.R. Rubinow, H.J. Whitfield Jr., C. May, R.M. Post, G.P. Chrousos, and P.W. Gold Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications Journal of Clinical Endocrinology and Metabolism 72 1991 260 271
11. E. Küçükibrahimoǧlu, M.Z. Saygin, M. Calişkan, O.K. Kaplan, C. Unsal, and M.Z. Gören The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression European Journal of Clinical Pharmacology 65 2009 571 577
12. J. Levine, K. Panchalingam, A. Rapoport, S. Gershon, R.J. McClure, and J.W. Pettegrew Increased cerebrospinal fluid glutamine levels in depressed patients Biological Psychiatry 47 2000 586 593
13. J. Liu, B. Yu, V. Neugebauer, D.E. Grigoriadis, J. Rivier, W.W. Vale, P. Shinnick-Gallagher, and J.P. Gallagher Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission Journal of Neuroscience 24 2004 4020 4029
14. J.M. Martinez, A. Garakani, R. Yehuda, and J.M. Gorman Proinflammatory and resiliency proteins in the CSF of patients with major depression Depression and Anxiety 29 2012 32 38
15. J.J. Miguel-Hidalgo, R. Waltzer, A.A. Whittom, M.C. Austin, G. Rajkowska, and C.A. Stockmeier Glial and glutamatergic markers in depression, alcoholism and their comorbidity Journal of Affective Disorders 127 2010 230 240
16. G. Nikisch, H. Agren, C.B. Eap, A. Czernik, P. Baumann, and A.A. Mathé Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram International Journal of Neuropsychopharmacology 8 2005 403 410
17. M.A. Oquendo, B. Halberstam, and J.J. Mann Risk factors for suicidal behavior: utility and limitations of research instruments M.B. First, Standardized Evaluation in Clinical Practice vol. 22 2003 American Psychiatric Publishing, Inc. Washington, DC 103 130
18. A. Roy, D. Pickar, S. Paul, A. Doran, G.P. Chrousos, and P.W. Gold CSF corticotropin-releasing hormone in depressed patients and normal control subjects American Journal of Psychiatry 144 1987 641 645
19. G. Sanacora, G. Treccani, and M. Popoli Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders Neuropharmacology 62 2012 63 77
20. M. Taylor, S.E. Murphy, S. Selvaraj, M. Wylezinkska, P. Jezzard, P.J. Cowen, and J. Evans Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy Journal of Psychopharmacology 22 2008 473 476
21. M.J. Taylor, R. Norbury, S. Murphy, S. Rudebeck, P. Jezzard, and P.J. Cowen Lack of effect of citalopram on magnetic resonance spectroscopy measures of glutamate and glutamine in frontal cortex of healthy volunteers Journal of Psychopharmacology 24 2010 1217 1221
22. R.C. Veith, N. Lewis, J.I. Langohr, M.M. Murburg, E.A. Ashleigh, S. Castillo, E.R. Peskind, M. Pascualy, G. Bissette, C.B. Nemeroff, and M.A. Raskind Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects Psychiatry Research 46 1993 1 8
23. D. Wasserman, J. Wasserman, and M. Sokolowski Genetics of HPA-axis, depression and suicidality European Psychiatry 25 2010 278 280
24. M.L. Wong, M.A. Kling, P.J. Munson, S. Listwak, J. Licinio, P. Prolo, B. Karp, I.E. McCutcheon, T.D. Geracioti Jr., M.D. DeBellis, K.C. Rice, D.S. Goldstein, J.D. Veldhuis, G.P. Chrousos, E.H. Oldfield, S.M. McCann, and P.W. Gold Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone Proceedings of the National Academy of Sciences of the United States of America 97 2000 325 330